Gala GLP-1 Review

What Gala GLP-1 charges

• NAD+: $199 — from; the seller prints "/month" beside a supply it defines as twenty-eight days
• NAD+: $118 — the effective rate on a twelve-month plan billed $1,417 up front
• Sermorelin: $199 — from; the seller prints "/month" beside a supply it defines as twenty-eight days
• Sermorelin: $118 — the effective rate on a twelve-month plan billed up front

Twenty-eight days is not a month, and it prints twenty-eight days

Its longevity pages label a rate per month and then state the supply length beside it as twenty-eight days.

Twenty-eight days is not a month, so both the NAD+ and the sermorelin rows are recorded as not monthly, with the seller's own unit noted against each.

Its twelve-month plan is billed once up front, and the per-month figure on that plan is a division of that single charge rather than something anyone is billed.

The weight-loss figures name two molecules at once

Its own page prints "Compounded semaglutide & tirzepatide options" above the figure, and its microdose page does the same thing.

One figure covering two molecules is not a price for either, so nothing is recorded for either drug.

Its entry price is stated two ways in any case: its FAQ gives one starting figure tied to a three-month plan, while the product pages give a lower one footnoted "*…Price calculated based on a yearly subscription plan." Both were declined.

It charges at checkout and says so before you get there

Its own words: "Charged at checkout — a licensed provider reviews before anything ships, and if they can't prescribe for you, you're refunded in full."

That is unusual and it is stated plainly rather than buried, so a reader knows the order of events before paying.

On the legal category it writes "*Compounded GLP-1 is not FDA-approved and is sourced from licensed compounding pharmacies", and repeats the point where a provider might prescribe one.

Its counters and its coverage lines are not claims

Its statistic counters animate in JavaScript and render as zeroes, so no efficacy figure on those pages is a readable claim at all.

Its coverage lines are counts about other parties: "Licensed providers in all 50 states" and "We work with a wide network of pharmacies across all 50 states."

No coverage list is published, so no fifty-state claim is credited here, and no dispensing pharmacy is named.

How we verified this

• Recorded the seller's own unit — a twenty-eight-day supply — rather than reading the per-month label printed beside it as a month.
• Confirmed the weight-loss figures sit under a heading naming both molecules, on the main page and the microdose page alike, and filed neither.
• Read the FAQ entry price against the product-page entry price, found they rest on different plan terms, and declined both rather than picking one.
• Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
• Screened the brand, its compact spelling and its legal entity against the live federal warning-letter table, pulling all 3,677 records in pages and filtering locally because the table's own search parameter is ignored, through a matcher that normalises both the query and the filed company name before comparing, with a positive and a nonsense control in the same run.